Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: April 1, 2023

Details for Patent: 6,774,104

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

Summary for Patent: 6,774,104
Title: Stabilized pharmaceutical composition in lyophilized form
Abstract:A stabilized pharmaceutical composition in lyophilized form comprising: a cyclic polypeptide compound represented by the general formula (I): ##STR1## wherein R.sup.1 is a hydrogen atom or an acyl group and R.sup.2 and R.sup.3 are, the same or different, a hydrogen atom or a hydroxyl group, or a salt thereof and the stabilizer.
Inventor(s): Sawai; Seiji (Hyogo, JP), Kasai; Akihiro (Nara, JP), Otomo; Kazumi (Osaka, JP)
Assignee: Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:09/786,125
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,774,104
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation; Use;

Drugs Protected by US Patent 6,774,104

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,774,104

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan11/187713Jul 01, 1999
PCT Information
PCT FiledJune 29, 2000PCT Application Number:PCT/JP00/04381
PCT Publication Date:January 11, 2001PCT Publication Number: WO01/02002

International Family Members for US Patent 6,774,104

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 024634 ⤷  Sign Up
Austria 280583 ⤷  Sign Up
Australia 5572200 ⤷  Sign Up
Australia 752265 ⤷  Sign Up
Brazil 0006823 ⤷  Sign Up
Canada 2341568 ⤷  Sign Up
China 100352495 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.